316 related articles for article (PubMed ID: 10873480)
1. Evaluation of platelet function by flow cytometry.
Michelson AD; Barnard MR; Krueger LA; Frelinger AL; Furman MI
Methods; 2000 Jul; 21(3):259-70. PubMed ID: 10873480
[TBL] [Abstract][Full Text] [Related]
2. Laboratory markers of platelet activation and their clinical significance.
Michelson AD; Furman MI
Curr Opin Hematol; 1999 Sep; 6(5):342-8. PubMed ID: 10468151
[TBL] [Abstract][Full Text] [Related]
3. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.
Tomer A
J Biol Regul Homeost Agents; 2004; 18(2):172-7. PubMed ID: 15471223
[TBL] [Abstract][Full Text] [Related]
4. P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist.
Zhao L; Bath PM; May J; Lösche W; Heptinstall S
Platelets; 2003; 14(7-8):473-80. PubMed ID: 14713516
[TBL] [Abstract][Full Text] [Related]
5. [Flow cytometric 3-color analysis of circulating activated platelets and its clinical significance in ischemic cerebrovascular diseases].
Wang J; Cao L; He M
Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):499-502. PubMed ID: 11798806
[TBL] [Abstract][Full Text] [Related]
6. Development and assessment of enzyme immunoassay for platelet-derived microparticles.
Osumi K; Ozeki Y; Saito S; Nagamura Y; Ito H; Kimura Y; Ogura H; Nomura S
Thromb Haemost; 2001 Feb; 85(2):326-30. PubMed ID: 11246556
[TBL] [Abstract][Full Text] [Related]
7. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
Chung A; Wildhirt SM; Wang S; Koshal A; Radomski MW
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
[TBL] [Abstract][Full Text] [Related]
8. Detection of activated platelets and platelet-leukocyte aggregates in horses.
Weiss DJ; Evanson OA
Am J Vet Res; 1997 Aug; 58(8):823-7. PubMed ID: 9256963
[TBL] [Abstract][Full Text] [Related]
9. Detection of activated platelets in canine blood by use of flow cytometry.
Wills TB; Wardrop KJ; Meyers KM
Am J Vet Res; 2006 Jan; 67(1):56-63. PubMed ID: 16426212
[TBL] [Abstract][Full Text] [Related]
10. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
11. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric assay of platelet glycoprotein receptor numbers in hypercholesterolemia.
Ozsavci D; Yardimci T; Demirel GY; Demiralp E; Uras F; Onder E
Platelets; 2002 Jun; 13(4):223-9. PubMed ID: 12189024
[TBL] [Abstract][Full Text] [Related]
13. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.
Kleinschnitz C; Pozgajova M; Pham M; Bendszus M; Nieswandt B; Stoll G
Circulation; 2007 May; 115(17):2323-30. PubMed ID: 17438148
[TBL] [Abstract][Full Text] [Related]
14. Inhaled nitric oxide inhibits platelet-leukocyte interactions in patients with acute respiratory distress syndrome.
Gries A; Herr A; Kirsch S; Günther C; Weber S; Szabo G; Holzmann A; Böttiger BW; Martin E
Crit Care Med; 2003 Jun; 31(6):1697-704. PubMed ID: 12794407
[TBL] [Abstract][Full Text] [Related]
15. Do platelet apoptosis, activation, aggregation, lipid peroxidation and platelet-leukocyte aggregate formation occur simultaneously in hyperlipidemia?
Sener A; Ozsavci D; Oba R; Demirel GY; Uras F; Yardimci KT
Clin Biochem; 2005 Dec; 38(12):1081-7. PubMed ID: 16253220
[TBL] [Abstract][Full Text] [Related]
16. The complement factor properdin induces formation of platelet-leukocyte aggregates via leukocyte activation.
Ruef J; Kuehnl P; Meinertz T; Merten M
Platelets; 2008 Aug; 19(5):359-64. PubMed ID: 18791942
[TBL] [Abstract][Full Text] [Related]
17. Interactions of platelets with Synthocytes, a novel platelet substitute.
Davies AR; Judge HM; May JA; Glenn JR; Heptinstall S
Platelets; 2002 Jun; 13(4):197-205. PubMed ID: 12189020
[TBL] [Abstract][Full Text] [Related]
18. Multicolor flow cytometry for evaluation of platelet surface antigens and activation markers.
van Velzen JF; Laros-van Gorkom BA; Pop GA; van Heerde WL
Thromb Res; 2012 Jul; 130(1):92-8. PubMed ID: 22424855
[TBL] [Abstract][Full Text] [Related]
19. Correlated measurement of platelet release and aggregation in whole blood.
Ault KA; Rinder HM; Mitchell JG; Rinder CS; Lambrew CT; Hillman RS
Cytometry; 1989 Jul; 10(4):448-55. PubMed ID: 2475308
[TBL] [Abstract][Full Text] [Related]
20. [Whole blood flow cytometry for detection of activated platelets. I. Platelet identification, blood collection and storage].
Shimizu M; Ando Y; Takei M; Miyachi H; Tanaka Y; Kawada T
Rinsho Byori; 2001 Apr; 49(4):402-7. PubMed ID: 11391956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
